Gene therapy shows promise in the management of inherited peripheral neuropathy and the complex array of symptoms that patients experience. Gene therapy holds promise in the management of peripheral neuropathies and in significant improvement of quality of life for patients.
A team of researchers found several under-recognized features of CEDNIK syndrome when they assessed and reported on new patients with the rare genetic disease.
The researchers sought to evaluate the relationship between pain management and stimulant use in people with chronic pain.
Researchers developed a framework to differentiate PD- from non-PD-related pain and classify PD-related pain into 3 groups — nociceptive, neuropathic, or nociplastic.
Hizentra is indicated for the treatment of adult patients with CIDP as maintenance therapy to prevent relapse of neuromuscular disability and impairment.
Ischemic optic neuropathies are the most common acute optic nerve pathology in patients older than 50 years of age.
To help standardize peripheral nerve ultrasound protocols, study investigators pooled reference cross-sectional area values of lower extremity nerves.
One aim of this study was to compare breast cancer survivors and HIV patients, both with neuropathic pain, with regard to psychological factors and health-related quality of life.
The primary goal of this study was to evaluate long-term change in neurofilament light chain levels in response to patisiran in patients with ATTRv amyloidosis enrolled in the Global OLE study.
Investigators evaluated the characteristics and risk factors for neurologic adverse events associated with immune checkpoint inhibitors.
